Stay updated on Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical-trial record for abemaciclib plus nivolumab is displayed, with study design, participant criteria, outcomes, and record history. The study is listed as terminated, with no longer any recruitment.
    Difference
    58%
    Check dated 2026-11-08T05:54:50.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T03:28:21.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A notice appears above the ClinicalTrials.gov page announcing that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T03:59:58.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T03:28:43.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer's site revision identifier changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T03:53:46.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content and navigation with an error message. This indicates restricted access to the trial information for the NCT03655444 study.
    Difference
    20%
    Check dated 2026-09-20T02:07:27.000Z thumbnail image

Stay in the know with updates to Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.